Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Classical hematology 4

Conditions

Hemophilia A 4Anemia, Sickle Cell 4Thrombocytopenia 2Anemia 2Venous Thromboembolism 1Vaso-Occlusive Crises 1Renal Anemia 1Purpura, Thrombocytopenic, Idiopathic 1Purpura, Thrombocytopenic 1Priapism 1Ovarian Neoplasms 1Myelodysplastic Syndromes 1Leukemia, Lymphocytic, Chronic, B-Cell 1Fanconi Anemia, Complementation Group D1 1

Interventions

voxelotor 1maltodextrin 1Glutamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has announcements × Anemia, Sickle Cell × Classical hematology × Clear all
NCT03036813 2023-07-27

GBT_HOPE

Pfizer

Phase 3 Completed
449 enrolled 17 charts 1 FDA
Classical hematology

Anemia, Sickle Cell

NCT01179217 2020-08-19

A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

Emmaus Medical, Inc.

Phase 3 Completed
230 enrolled 19 charts 1 FDA
Classical hematology

Vaso-Occlusive Crises, Anemia, Sickle Cell

NCT02516579 2020-03-19

ESCORT-HU

Theravia

Completed
1,906 enrolled 9 charts 1 FDA
Classical hematology

Anemia, Sickle Cell

NCT01895361 2020-01-31

SUSTAIN

Reprixys Pharmaceutical Corporation

Phase 2 Completed
198 enrolled 18 charts 1 FDA
Classical hematology

Anemia, Sickle Cell, Priapism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡